Replies to post #313571 on Avid Bioservices Inc (CDMO)

[biopharm]

I always thought that mention of Beijing was to throw some off track...would be interesting if China approval comes first ahead of FDA USA approval (which may add up with that lawsuit saying addition to BOD after approval)

No mention of where that approval would be....or for what indication

Steve Worsley with an interesting change in his LinkedIn profile...

Member Board Of Directors
Peregrine Pharmaceuticals Beijing, Ltd.
2013 – Present (4 years) | Beijing City, China

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129518118

[biopharm]

CP, probabilities increase that some type of deal being worked on in China, especially when Chinese websites pick up the news

Notice the late Dr Phil Thorpe on Dr Brekkens presentation ....and I doubt it was coincidence

Would have been nice to sit in on this conversation as MDs and researches must vet PS Targeting new knowledge ....and AstraZeneca does much research with this same University

http://www.gzsums.net/news_16888.aspx

(The way I see it, RONIN group wants to pay a middle man to possibly pay them way undervalued sums of breadcrumbs for PS Targeting ...as Peregrine continues the path for making others realize the true value of PS Targeting and cuts out the middle man, maximizing shareholder value in ways RONIN group does not seem prepared to do ....)